Chimeric Therapeutics Ltd. Financial Overview
Chimeric Therapeutics Ltd.'s market cap is currently AU$10.93M. The company's EPS TTM is AU$-0.004; its P/E ratio is -1.69; Chimeric Therapeutics Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
